Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10973871
Ophthalmic compositions
granted -
US 10973862
Bifidobacterium longum for treating obesity and associated metabolic disorders
granted -
US 10973841
Compositions for the treatment of skin conditions
granted -
US 10973869
Methods of treating cardiomyopathy associated with genetic disorders
granted -
US 10973861
Compositions and methods
granted -
US 10975375
Methods and compositions for regulation of transgene expression
granted -
US 10974041
Neuromodulation device
granted -
US 10973844
TALEN-based gene correction
granted -
US 10973813
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 10975393
Engineered target specific nucleases
granted -
US 10973805
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 10975094
Heterocyclic compounds as RSV inhibitors
granted -
US 10973764
Neuroprotective liposome compositions and methods for treatment of stroke
granted -
US 10973817
Pharmaceutical compounds
granted -
US 10973758
Methods of eye treatment using therapeutic compositions containing dipyridamole
granted -
US 10973812
Ataxia therapeutic compositions and methods
granted -
US 10975355
Controlled induction of human pancreatic progenitors produces functional beta-like cells
granted -
US 10975167
Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase
granted -
US 10975166
Inhibitory antibodies against MMP-14
granted -
US 10975139
Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments
granted -
US 10975150
Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodies
granted -
US 10975158
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
granted -
US 10975365
Di-enzymatic chimeric endolysin
granted -
US 10973894
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.